
The DEA’s Cannabis Reclassification: A Shift in Federal Drug Policy and Its Broader Implications
The U.S. Drug Enforcement Administration’s (DEA) recent proposal to reclassify “botanical cannabis” from Schedule I to Schedule III marks a pivotal shift in federal drug…